Aspen Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 24-10-2024
- Paid Up Capital ₹ 8.44 M
as on 24-10-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.00 Cr
as on 24-10-2024
- Revenue -16.55%
(FY 2023)
- Profit -26.51%
(FY 2023)
- Ebitda -23.97%
(FY 2023)
- Net Worth 20.04%
(FY 2023)
- Total Assets 7.10%
(FY 2023)
About Aspen Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 8.44 M.
The company has closed loans amounting to ₹4.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bharat Jindal and Lalita Jindal serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PTC071727
- Company No.
071727
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aspen Diagnostics Private Limited offer?
Aspen Diagnostics Private Limited offers a wide range of products and services, including Health Conditions, Respiratory Care.
Who are the key members and board of directors at Aspen Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Jindal  | Director | 21-Aug-1995 | Current |
| Lalita Jindal | Director | 21-Aug-1995 | Current |
Financial Performance of Aspen Diagnostics.
Aspen Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.55% decrease. The company also saw a substantial fall in profitability, with a 26.51% decrease in profit. The company's net worth Soared by an impressive increase of 20.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspen Diagnostics?
In 2023, Aspen Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rapid Diagnostic Private LimitedActive 29 years 2 monthsBharat Jindal and Lalita Jindal are mutual person
Charges (Loans)
₹0
₹40.00 M
Charges Breakdown by Lending Institutions
- Others : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2017 | Others | ₹4.00 Cr | Satisfied |
How Many Employees Work at Aspen Diagnostics?
Aspen Diagnostics has a workforce of 157 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspen Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspen Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
